[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507246":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":40,"collaborators":7,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":49,"minAge":7,"maxAge":7,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Magdi Yacoub Heart Foundation","OTHER",null,[9,13],{"name":10,"role":11,"phone":7,"phoneExt":7,"email":12},"Magdi H Yacoub, FRS OM","CONTACT","m.yacoub@imperial.ac.uk",{"name":14,"role":11,"phone":15,"phoneExt":7,"email":16},"Shehab M Anwer, MBBCh., MRes","+41788816333","shehabanwer@gmail.com",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":7,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Aswan Heart Centre - Magdi Yacoub Heart Foundation","RECRUITING","Aswān","Egypt","EG",{"type":25,"coordinates":26},"Point",[27,28],32.89942,24.09082,{"lat":28,"lon":27},[31,35,37],{"name":32,"role":11,"phone":33,"phoneExt":7,"email":34},"Ahmed M ElGuindy, MD, MRCP","+201001615151","ahmed_elguindy@hotmail.com",{"name":36,"role":11,"phone":15,"phoneExt":7,"email":16},"Shehab M Anwer, MBBCh, MRes, PhD",{"name":38,"role":39,"phone":7,"phoneExt":7,"email":7},"Magdi H Yacoub, OM FRS","PRINCIPAL_INVESTIGATOR",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100507246","egyptian-hypertrophic-cardiomyopathy-program-100507246",false,"NCT05884892","Egyptian Hypertrophic Cardiomyopathy Program","Inclusion Criteria:\n\n* All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.\n* All family members of index patients who are willing and consented to participate in the registry.\n\nExclusion Criteria:\n\n* Refusal to consent to participate in the registry program.",true,"ALL",{"count":51,"type":52},2000,"ESTIMATED","10 Years","OBSERVATIONAL","Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.",[57],"Hypertrophic Cardiomyopathy",[59,60,57,61,62,63],"HCM","HOCM","Familial Hypertrophic Cardiomyopathy","Hypertrophic Cardiomyopathy with Genetic Marker","Hypertrophic Obstructive Cardiomyopathy","2023-05-23",{"date":66,"type":67},"2023-06-01","ACTUAL",{"date":69,"type":67},"2014-01-01",{"date":71,"type":52},"2030-01-01",{"name":5,"class":6},1]